VIM metallo-␤-lactamase-producing serotype O11 or O12 Pseudomonas aeruginosa isolates infecting or colonizing 19 patients from seven hospitals in Hungary were characterized between October 2003 and November 2005. Macrorestriction analysis revealed the involvement of hospitals from three different towns in northwest Hungary in an outbreak caused by VIM-4-producing P. aeruginosa.
The worldwide spread of acquired metallo-␤-lactamase (MBL)-producing gram-negative pathogens was observed in the past decade, with the bla VIM -type acquired MBL genes currently being the most prevalent in Europe (16, 23) . The first VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary (isolates PA396 and PA450) were characterized at the National Center for Epidemiology in 2003 (7) . We established routine screening of carbapenem-resistant Pseudomonas sp. isolates provided by collaborating regional laboratories for acquired MBL genes. In 2005, MBL-positive isolates from six towns in Hungary were detected (Fig. 1 ). Our aim was to characterize these isolates and to examine the clonal relationships between them and between the major European multiresistant serotype O12 P. aeruginosa clone, clone P12 (4, 8, 10) .
The VIM-positive clinical and environmental isolates tested in this study are listed in Table 1 , together with the previously published control isolates PA396 and PA450 (7) . Isolates P12-Q and P12-E were from French patients "Q" and "E," respectively, who participated in a previous clone P12-related study (8) . MICs were determined by the agar dilution method (1) for ␤-lactam antibiotics and by the Etest (AB Biodisk, Solna, Sweden) for other antibiotics. The MBL Etest and the imipenem-EDTA, ceftazidime-EDTA, and cefepime-EDTA double-disk methods were used for phenotypic screening (21, 22) .
bla VIM genes and class 1 integrons were detected by PCR (7). The variable regions of the integrons from isolates PA555 and MB197 were sequenced by using the following primers, together with those described previously (7): primer 197F (5Ј-AAT   CGC TCA GTC GCC GAG-3Ј), primer 197R1 (5Ј-TAG TGC  TTC TCC GTC GGG-3Ј), primer 197R2 (5Ј-AAT TCC GCA  TTG CTG ATC G-3Ј), and primer 197R3 (5Ј-AGG TAT TGC  TCC TGC ACT T-3Ј) . Isolate PA555 was selected for full integron sequencing in 2003, as it was the first VIM-positive isolate from Pécs, Hungary, while isolate MB197 was selected as an invasive isolate from a cluster of clonally closely related VIMpositive isolates from northwest Hungary. For the other VIMproducing isolates, the integron structures were determined by PCR mapping and partial sequencing.
Pulsed-field gel electrophoresis (PFGE) was performed as described earlier (11) , with modifications, and the patterns were interpreted by using Fingerprinting II Informatix software (Bio-Rad, Madrid, Spain). Pseudomonas aeruginosa antisera (Bio-Rad, Marnes-la-Coquette, France) were used for serotyping.
Conjugation experiments were carried out with strains Escherichia coli J5-3 Rif r and P. aeruginosa PAO4089Rp (6, 7) as the recipients. Transconjugants were selected on Mueller-Hinton agar plates containing 300 g/ml rifampin and 32 g/ml cefotaxime, 128 g/ml piperacillin-tazobactam, or 128 g/ml ticarcillin.
A total of 758 carbapenem-resistant Pseudomonas sp. isolates collected on a voluntary basis from 85 epidemiological settings in 42 towns in Hungary were screened for MBL production between October 2003 and November 2005. The settings are distributed in every geographical region of Hungary. Fifty P. aeruginosa isolates and one P. putida isolate (isolate PP524) proved to be positive by the phenotypic tests. Seven of these positive isolates from a Budapest hospital were not included in this study. PCRs with VIM-and integron-specific primers (7) gave positive results for all these isolates. The bla VIM genes of the isolates indicated by a superscript g in Table 1 were sequenced and were identified as bla VIM-4 in every case. P12-Q and P12-E were negative by the MBL phenotypic tests.
Antibiotic susceptibility values for representative VIM-positive isolates and isolate P12-Q are shown in Table 2 . All isolates were multidrug resistant, and some of them were only sensitive to aztreonam. Isolate MB397 was panresistant to all antimicrobials tested.
Two major groups could be identified among the VIMpositive P. aeruginosa isolates by serotyping and PFGE. Their geographical distribution is shown in Fig. 1 . The first group comprised serotype O12 isolates from Budapest and Pécs (Table 1) . These isolates were possibly related to each other, as determined by PFGE, and also to representative isolates of the major European P12 clone when a cutoff value of Ն80% was used (17) (18) (19) . The O12 isolates from Budapest and Pécs carry an integron-borne bla VIM-4 gene with an identical 170-bp duplication in the last position, preceded by an aacA4 gene (Fig. 2, integrons a and b ). An additional bla OXA cassette is present in the first position of integron a from Budapest (Table 1 ) (7).
The second group comprised all isolates from the Győr, Sopron, and Mosonmagyaróvár hospitals. These serotype O11 isolates were identical or closely related to each other by PFGE by use of a Dice coefficient of Ն95% (Table 1) of this integron were identified (Fig. 2, integrons c and d) , with the only difference being that an additional aacA7 cassette was present in the first position of integron c. We identified a carrier patient (patient P14) who was transferred between the intensive care units (ICUs) of the Győr and Mosonmagyaróvár hospitals, providing an epidemiological link between them. Another patient (patient P13) with no related clinical history was identified as a carrier on admission to the hospital, suggesting the presence of VIM-positive strains in the community. These results demonstrate the involvement of institutions from three towns in an outbreak of VIM-4-producing P. aeruginosa. Our observations and the available literature (2, 20, 23) underscore the role of human carriers and the hospital environment as potential reservoirs for MBL-producing P. aeruginosa strains.
Mating-out assays were performed with the isolates underlined in Table 1 . These experiments did not result in transconjugants under the experimental conditions applied, suggesting that the integrons are located either on the chromosome or on nonconjugative plasmids (12, 15) . While integrons a, c, and d have so far been reported only from Hungary, class 1 integrons carrying the same gene cassettes in their variable regions as integron b were also identified in Poland and Belgium (3, 7, 9; P. Bogaerts, H. Rodriguez, C. Bauraing, A. Deplano, Y. Glupczynski, and M. J. Struelens, Abstr. 15th Eur. Congr. Clin. Microbiol. Infect. Dis., abstr. P929, 2006). The rates of imipenem resistance among P. aeruginosa clinical isolates in Hungary rose from 5.4% in 1996 to 13% in 2005 (5) . The prevalence of VIM-positive P. aeruginosa isolates was estimated in the epidemiological settings from which the isolates were collected. On the basis of our experimental results and data from the National Bacteriological Surveillance database, we estimate that in 2004, VIM producers constituted about 0.4% and 0.05% of the imipenem-resistant isolates and all P. aeruginosa clinical isolates, respectively. In 2005, these values rose to about 6.5% and 0.8%, respectively. The observed increase could mainly be attributed to the clonal spread of the serotype O11 VIM-4-positive P. aeruginosa isolates in northwest Hungary. This is the first report of an outbreak caused by acquired MBL-producing pathogens in Hungary. In hospitals in Greece, Italy, Korea, and Colombia, the dissemination of integrons carrying the bla VIM-1 , bla VIM-2 , or bla VIM-8 gene mostly occurred in serotype O11 and O12 clones of P. aeruginosa (2, 6, 14, 20) . These studies, as well as ours, indicate that serotype O11 and O12 multiresistant clones of P. aeruginosa (13) play an important role in the dissemination of bla VIM through clonal spread but that other mechanisms, such as horizontal transfer, are also involved (3, 16, 23) .
Nucleotide sequence accession numbers. The sequences of bla VIM harboring integrons were deposited in GenBank under accession numbers AY702100 and DQ357197.
